Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
| Errataetall: |
CommentIn: Lancet. 2022 Apr 16;399(10334):1464-1465. - PMID 35334211 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:399 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 399(2022), 10319 vom: 01. Jan., Seite 21-22 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Heskin, Joseph [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7R9A5P7H32 |
|---|
| Anmerkungen: |
Date Completed 25.01.2022 Date Revised 17.12.2022 published: Print CommentIn: Lancet. 2022 Apr 16;399(10334):1464-1465. - PMID 35334211 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(21)02657-X |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335091970 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335091970 | ||
| 003 | DE-627 | ||
| 005 | 20231225225056.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(21)02657-X |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1116.xml |
| 035 | |a (DE-627)NLM335091970 | ||
| 035 | |a (NLM)34973713 | ||
| 035 | |a (PII)S0140-6736(21)02657-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Heskin, Joseph |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.01.2022 | ||
| 500 | |a Date Revised 17.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Lancet. 2022 Apr 16;399(10334):1464-1465. - PMID 35334211 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Lactams |2 NLM | |
| 650 | 7 | |a Nitriles |2 NLM | |
| 650 | 7 | |a Viral Protease Inhibitors |2 NLM | |
| 650 | 7 | |a nirmatrelvir |2 NLM | |
| 650 | 7 | |a 7R9A5P7H32 |2 NLM | |
| 650 | 7 | |a Proline |2 NLM | |
| 650 | 7 | |a 9DLQ4CIU6V |2 NLM | |
| 650 | 7 | |a Leucine |2 NLM | |
| 650 | 7 | |a GMW67QNF9C |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Pallett, Scott J C |e verfasserin |4 aut | |
| 700 | 1 | |a Mughal, Nabeela |e verfasserin |4 aut | |
| 700 | 1 | |a Davies, Gary W |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Luke S P |e verfasserin |4 aut | |
| 700 | 1 | |a Rayment, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Rachael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 399(2022), 10319 vom: 01. Jan., Seite 21-22 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:399 |g year:2022 |g number:10319 |g day:01 |g month:01 |g pages:21-22 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(21)02657-X |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 399 |j 2022 |e 10319 |b 01 |c 01 |h 21-22 | ||